We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Danaher (DHR) Q4 Earnings & Revenues Beat Estimates, Up Y/Y
Read MoreHide Full Article
Danaher Corporation (DHR - Free Report) reported better-than-expected bottom-line results for the fourth quarter of 2018, delivering a positive surprise of 0.8%. This is the company’s 12th consecutive quarter of earnings beat.
The company’s adjusted earnings in the reported quarter were $1.28 per share, surpassing the Zacks Consensus Estimate of $1.27. Moreover, the bottom line increased 7.6% from the year-ago quarter’s figure of $1.19. The upside can be primarily attributed to impressive sales growth and improved operating income.
For full-year 2018, Danaher’s adjusted earnings came in at $4.52 per share, up 12% on a year-over-year basis.
Inside the Headiness
For the quarter under review, Danaher’s net sales were $5,363.5 million, up 5.5% from the year-ago quarter. Organic sales grew 5.5% and acquired assets had a positive 2% impact. However, foreign currency translations had a negative impact of 2%. Further, the sales figure surpassed the Zacks Consensus Estimate of $5,321 million.
For 2018, Danaher reported net sales of $19,893 million, up 8.5% on a year-over-year basis.
Danaher Corporation Price, Consensus and EPS Surprise
The company reports its net sales in four segments — Life Sciences, Diagnostics, Dental and Environmental & Applied Solutions. The segmental information is briefly discussed below:
Life Sciences generated revenues of $1,793.5 million, up 10.4% year over year. Operating income for the segment increased 9.1% to $353.7 million, primarily on the back of increased sales volumes. Diagnostics’ revenues increased 3.7% to $1,684.5 million. The segment’s operating income remained stable at $317.4 million.
Dental revenues remained relatively stable year over year at $759 million. Moreover, operating income increased 5.6% to $104.9 million. Environmental & AppliedSolutions witnessed revenue growth of 4.5% to $1,126.5 million. Also, the segment’s operating income increased 2.8% to $255.5 million.
Mixed Margin Profile
Danaher’s cost of sales increased 7.2% year over year to $2,407.6 million in the fourth quarter. It represented 44.9% of net sales compared with 44.2% in the year-ago quarter. Gross margin in the quarter declined 70 basis points (bps) to 55.1%.
Selling, general and administrative expenses increased 4.4% year over year to $1,673.7 million. It represented 31.2% of net sales. Research and development expenses were $319.6 million, up %. It represented 6% of net sales.
Operating income in the quarter under review increased 2.7% year over year to $962.6 million. However, operating profit margin for the reported quarter declined 50 bps to 17.9%.
Liquidity
As of Dec 31, 2018, Danaher had cash and equivalents of $787.8 million compared with the year-ago figure of $630.3 million.
Notably, the company paid dividends worth $433.4 million to shareholders in 2018.
Outlook
Danaher believes sturdier demand for innovative products will continue to drive its revenues in the quarters ahead. Also, robust top-line performance and effective Danaher Business System implementation will likely bolster profitability.
Concurrent with the earnings release, Danaher provided guidance for first-quarter 2019. The company projects adjusted earnings per share in the range of $1.00-$1.03.
Moreover, Danaher provided full-year 2019 adjusted earnings guidance. The company currently expects adjusted net earnings per share in the band of $4.75-$4.85.
Hitachi delivered average earnings surprise of 55.51% in the trailing four quarters.
Carlisle pulled off average positive earnings surprise of 11.90% in the trailing four quarters.
HC2 Holdings outpaced estimates in the last reported quarter by 111.90%.
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Image: Bigstock
Danaher (DHR) Q4 Earnings & Revenues Beat Estimates, Up Y/Y
Danaher Corporation (DHR - Free Report) reported better-than-expected bottom-line results for the fourth quarter of 2018, delivering a positive surprise of 0.8%. This is the company’s 12th consecutive quarter of earnings beat.
The company’s adjusted earnings in the reported quarter were $1.28 per share, surpassing the Zacks Consensus Estimate of $1.27. Moreover, the bottom line increased 7.6% from the year-ago quarter’s figure of $1.19. The upside can be primarily attributed to impressive sales growth and improved operating income.
For full-year 2018, Danaher’s adjusted earnings came in at $4.52 per share, up 12% on a year-over-year basis.
Inside the Headiness
For the quarter under review, Danaher’s net sales were $5,363.5 million, up 5.5% from the year-ago quarter. Organic sales grew 5.5% and acquired assets had a positive 2% impact. However, foreign currency translations had a negative impact of 2%. Further, the sales figure surpassed the Zacks Consensus Estimate of $5,321 million.
For 2018, Danaher reported net sales of $19,893 million, up 8.5% on a year-over-year basis.
Danaher Corporation Price, Consensus and EPS Surprise
Danaher Corporation Price, Consensus and EPS Surprise | Danaher Corporation Quote
The company reports its net sales in four segments — Life Sciences, Diagnostics, Dental and Environmental & Applied Solutions. The segmental information is briefly discussed below:
Life Sciences generated revenues of $1,793.5 million, up 10.4% year over year. Operating income for the segment increased 9.1% to $353.7 million, primarily on the back of increased sales volumes. Diagnostics’ revenues increased 3.7% to $1,684.5 million. The segment’s operating income remained stable at $317.4 million.
Dental revenues remained relatively stable year over year at $759 million. Moreover, operating income increased 5.6% to $104.9 million. Environmental & Applied Solutions witnessed revenue growth of 4.5% to $1,126.5 million. Also, the segment’s operating income increased 2.8% to $255.5 million.
Mixed Margin Profile
Danaher’s cost of sales increased 7.2% year over year to $2,407.6 million in the fourth quarter. It represented 44.9% of net sales compared with 44.2% in the year-ago quarter. Gross margin in the quarter declined 70 basis points (bps) to 55.1%.
Selling, general and administrative expenses increased 4.4% year over year to $1,673.7 million. It represented 31.2% of net sales. Research and development expenses were $319.6 million, up %. It represented 6% of net sales.
Operating income in the quarter under review increased 2.7% year over year to $962.6 million. However, operating profit margin for the reported quarter declined 50 bps to 17.9%.
Liquidity
As of Dec 31, 2018, Danaher had cash and equivalents of $787.8 million compared with the year-ago figure of $630.3 million.
Notably, the company paid dividends worth $433.4 million to shareholders in 2018.
Outlook
Danaher believes sturdier demand for innovative products will continue to drive its revenues in the quarters ahead. Also, robust top-line performance and effective Danaher Business System implementation will likely bolster profitability.
Concurrent with the earnings release, Danaher provided guidance for first-quarter 2019. The company projects adjusted earnings per share in the range of $1.00-$1.03.
Moreover, Danaher provided full-year 2019 adjusted earnings guidance. The company currently expects adjusted net earnings per share in the band of $4.75-$4.85.
Zacks Rank & Key Picks
Danaher currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the same space are Hitachi Ltd. (HTHIY - Free Report) , Carlisle Companies Incorporated (CSL - Free Report) and HC2 Holdings, Inc. . While Hitachi sports a Zacks Rank #1 (Strong Buy), Carlisle and HC2 Holdings carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Hitachi delivered average earnings surprise of 55.51% in the trailing four quarters.
Carlisle pulled off average positive earnings surprise of 11.90% in the trailing four quarters.
HC2 Holdings outpaced estimates in the last reported quarter by 111.90%.
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Click for details >>